MAPK3 and acute kidney injury: In conclusion, our data support the tenet that SHP2 inhibition attenuates AKI induced by our double-hit model of Hem/CLP and that this protective action may be attributable to its anti-inflammatory property in mitigating activation of the Erk1/2 and STAT3 signaling pathway.